Keywords: genasense, shows, benefits, cll, trial, new, jersey

Genasense shows benefits in CLL trial

Article | 27 February 2006

New Jersey, USA-based Genta says that data from Phase III trials of Genasense (oblimersen sodium), used in conjunction with chemotherapy ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in